MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities$298,085K Cash and cashequivalents$67,487K Prepaid expenses andother current assets$19,138K Collaboration receivable -related party$16,270K Other receivable$8,105K Total current assets$409,085K Right-of-use operating asset$9,957K Other long-termassets$1,756K Restricted cash$1,450K Property and equipment,net$674K Total assets$422,922K Total liabilities andstockholders equity$422,922K Total stockholdersequity$368,737K Total liabilities$54,185K Accumulated deficit-$3,082,191K Treasury stock, at cost,3,033 shares at june...$400K Additional paid-in capital$3,451,307K Total currentliabilities$44,642K Operating leaseliability, net of current...$9,543K Accumulated othercomprehensive income$15K Common stock, 0.0001par value per share...$6K Accrued expenses$42,072K Operating leaseliability, current portion$1,878K Accounts payable$692K
Balance Sheet
source: myfinsight.com

Sage Therapeutics, Inc. (SAGE)

Sage Therapeutics, Inc. (SAGE)